Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 213,000 | 864,000 | 1,641,000 | 1,452,000 | 1,668,000 |
| Receivables | 1,320,000 | 1,375,000 | 1,402,000 | 1,502,000 | 1,388,000 |
| Inventories | 894,000 | 891,000 | 853,000 | 725,000 | 684,000 |
| Income taxes - deferred | 429,000 | 572,000 | 911,000 | 679,000 | 369,000 |
| Other current assets | 576,000 | 578,000 | 0 | 1,119,000 | 1,447,000 |
| TOTAL | $3,615,000 | $4,599,000 | $5,452,000 | $5,941,000 | $6,030,000 |
| Non-Current Assets | |||||
| PPE Net | 1,697,000 | 1,722,000 | 1,728,000 | 1,715,000 | 1,644,000 |
| Investments And Advances | 0 | 0 | 0 | 317,000 | 596,000 |
| Intangibles | 16,529,000 | 18,603,000 | 19,665,000 | 23,067,000 | 22,378,000 |
| Other Non-Current Assets | 287,000 | 253,000 | 294,000 | 157,000 | 234,000 |
| TOTAL | $18,513,000 | $20,578,000 | $21,687,000 | $25,256,000 | $24,852,000 |
| Total Assets | $22,128,000 | $25,177,000 | $27,139,000 | $31,197,000 | $30,882,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 504,000 | 3,000 | 2,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 184,000 | 212,000 | 239,000 | 139,000 | 204,000 |
| Accrued Expenses | 1,626,000 | 2,609,000 | 2,612,000 | 2,541,000 | 1,816,000 |
| Other current liabilities | 295,000 | 198,000 | 380,000 | 192,000 | 191,000 |
| TOTAL | $2,609,000 | $3,022,000 | $3,233,000 | $3,250,000 | $2,631,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,934,000 | 5,915,000 | 6,743,000 | 7,933,000 | 8,895,000 |
| Other Non-Current Liabilities | 1,645,000 | 2,064,000 | 1,727,000 | 2,633,000 | 1,488,000 |
| TOTAL | $8,223,000 | $9,854,000 | $10,732,000 | $12,850,000 | $12,953,000 |
| Total Liabilities | $10,832,000 | $12,876,000 | $13,965,000 | $16,100,000 | $15,584,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,523,369 | 1,511,369 | 1,502,237 | 1,492,321 | 1,480,340 |
| Common Shares | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 |
| Retained earnings | -4,822,000 | -3,757,000 | -2,732,000 | -693,000 | -174,000 |
| Other shareholders' equity | -129,000 | -43,000 | -53,000 | -13,000 | -1,000 |
| TOTAL | $11,296,000 | $12,301,000 | $13,174,000 | $15,097,000 | $15,298,000 |
| Total Liabilities And Equity | $22,128,000 | $25,177,000 | $27,139,000 | $31,197,000 | $30,882,000 |